SCHEMBL3342597

SCHEMBL3342597

CC(=O)N1CCc2cc(S(=O)(=O)n3cc(N4CCNCC4)c4cccnc43)ccc21

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
TP53 P04637 3/20 0.48
MEN1 O00255 1/20 0.48
HPGD P15428 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPK1 P28482 1/20 0.48
LMNA P02545 1/20 0.47
TNF P01375 2/20 0.46
NOD2 Q9HC29 2/20 0.46
NOD1 Q9Y239 2/20 0.46
TSHR P16473 1/20 0.46
HTR6 P50406 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43
TRIM24 O15164 1/20 0.42
RAB9A P51151 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3338089 0.85 HTR6 (0.56) ALDH1A1TP53MAPK1LMNATNF
SCHEMBL3338245 0.85 MAPK1 (0.46) ALDH1A1TP53MEN1HPGDKMT2A
SCHEMBL3337569 0.82 HTR6 (0.53) HTR6
SCHEMBL3341097 0.80 MAPK1 (0.47) ALDH1A1TP53MEN1HPGDKMT2A
SCHEMBL3344398 0.78 HTR6 (0.49) ALDH1A1TP53MEN1HPGDKMT2A
SCHEMBL5009048 0.78 HTR6 (0.61) TP53MAPK1LMNATNFNOD2
SCHEMBL3337694 0.76 HTR6 (0.63) ALDH1A1TP53KMT2AMAPK1LMNA
SCHEMBL3338516 0.75 MAPK1 (0.52) ALDH1A1TP53MEN1HPGDKMT2A
SCHEMBL3334348 0.72 HTR6 (0.53) MAPK1HTR6
SCHEMBL5091056 0.72 TNF (0.55) TP53MAPK1LMNATNFNOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152177-A1 COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-06-17 US claimed
US-20080039462-A1 Compounds having 5-HT6 receptor affinity MEMORY PHARMACEUTICALS CORPORATION 2008-02-14 US claimed
US-20100152177-A1 COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-06-17 US disclosed
US-20100152177-A1 COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-06-17 US disclosed
US-20100152177-A1 COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2010-06-17 US disclosed
US-7696229-B2 Compounds having 5-HT6 receptor affinity MEMORY PHARMACEUTICALS CORPORATION (US) 2010-04-13 US disclosed
US-7696229-B2 Compounds having 5-HT6 receptor affinity MEMORY PHARMACEUTICALS CORPORATION (US) 2010-04-13 US disclosed
US-7696229-B2 Compounds having 5-HT6 receptor affinity MEMORY PHARMACEUTICALS CORPORATION (US) 2010-04-13 US disclosed
US-20080039462-A1 Compounds having 5-HT6 receptor affinity MEMORY PHARMACEUTICALS CORPORATION 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152177-A1 COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR3B, HTR1B ALDH1A1 1263/4885TP53 4828/4885MEN1 1716/4885
US-20080039462-A1 Compounds having 5-HT6 receptor affinity HTR6, HTR3B, HTR1B ALDH1A1 1263/4885TP53 4828/4885MEN1 1716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.